Topics

Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

03:30 EDT 5 Sep 2019 | Accesswire

NEW YORK, NY / ACCESSWIRE / September 5, 2019 / Crescita Therapeutics Inc. (TSX:CTX)(OTC Pink:CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases and their symptoms, today announced that its executive chairman, Dan Chicoine will be presenting at this year's Fall Investor Summit on Monday, September 16th at 1:00 p.m. eastern time in New York City. Mr. Chicoine accompanied by Ms. Linda Kisa, Crescita's director of investor relations, will also be meeting with investors one-on-one during the event.

The Fall Investor Summit will take place at the Essex House, featuring 160 companies and over 1,000 institutional and retail investors.

About Crescita Therapeutics Inc.

Crescita (TSX:CTX) (OTC Pink:CRRTF) is a publicly traded, Canadian commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Please visit www.crescitatherapeutics.com for additional information.

About The Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting small cap and microcap companies with qualified investors.
To register as a presenting company: please contact Cassandra Miller (cassandra@microcapconf.com)
To request complimentary investor registration: please visit our website at www.microcapconf.com

FOR MORE INFORMATION

Please visit: www.microcapconf.com
Or, contact Ashley Allard at ashley@microcapconf.com

Investor Relations
Email: ir@crescitatx.com

Or

Glen Akselrod
Bristol Capital
Tel: 1-905-326-1888, extension 10
Email: glen@bristolir.com

News Compliments of ACCESSWIRE

SOURCE: Crescita Therapeautics Inc.



View source version on accesswire.com:
https://www.accesswire.com/558538/Crescita-Therapeutics-Inc-to-Present-at-the-Fall-Investor-Summit-on-September-16th-17th-in-New-York-City

Original Article: Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

NEXT ARTICLE

More From BioPortfolio on "Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City"

Quick Search

Relevant Topics

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...